TABLE 1.
Protection of horses based on body temperature, nasal shedding of infectious virus, and cell-associated viremia after challenge infection with EHV-1a
Horse information |
Maximum feverb |
Maximum sheddingc |
Maximum viremiad |
|||||
---|---|---|---|---|---|---|---|---|
EHV-1 protection status | ID | Group | °C | Hours p.i. | PFU/ml | Day p.i. | CTe | Day p.i. |
Fully protected | 1 | Ab4ORF2/Ab4 | No fever | NA | No shedding | NA | No viremia | NA |
8 | Ab4ORF2/Ab4 | No fever | NA | No shedding | NA | No viremia | NA | |
14 | Ab4ORF2/Ab4 | No fever | NA | No shedding | NA | No viremia | NA | |
18 | Ab4ORF2/Ab4 | No fever | NA | No shedding | NA | No viremia | NA | |
23 | Ab4ORF2/Ab4 | No fever | NA | No shedding | NA | No viremia | NA | |
6 | Ab4/Ab4 | No fever | NA | No shedding | NA | No viremia | NA | |
11 | Ab4/Ab4 | No fever | NA | No shedding | NA | No viremia | NA | |
24 | Ab4/Ab4 | No fever | NA | No shedding | NA | No viremia | NA | |
Partially protected | 2 | Ab4ORF2/Ab4 | No fever | NA | No shedding | NA | 36.96 | 8 |
12 | Ab4ORF2/Ab4 | 38.9 | NA | No shedding | NA | No viremia | NA | |
17 | Ab4ORF2/Ab4 | No fever | NA | 10 | 1 | No viremia | NA | |
4 | Ab4/Ab4 | No fever | NA | 30 | 1 | 35.82 | 6 | |
10 | Ab4/Ab4 | No fever | NA | No shedding | NA | 36.96 | 7 | |
13 | Ab4/Ab4 | No fever | NA | 140 | 2 | No viremia | NA | |
16 | Ab4/Ab4 | No fever | NA | 2,900 | 1 | No viremia | NA | |
21 | Ab4/Ab4 | No fever | NA | No shedding | NA | 30.20 | 8 | |
Susceptible | 3 | Control/Ab4 | 41.2 | 36 | 19,500 | 3 | 31.25 | 6 |
5 | Control/Ab4 | 41.4 | 48 | 700,000 | 2 | 30.43 | 4 | |
7 | Control/Ab4 | 41.1 | 60 | 29,500 | 2 | 30.13 | 6 | |
9 | Control/Ab4 | 40.9 | 48 | 8,000 | 2 | 35.43 | 8 | |
15 | Control/Ab4 | 41.6 | 48 | 240,000 | 2 | 33.71 | 5 | |
19 | Control/Ab4 | 41.3 | 36 | 7,550 | 3 | 32.59 | 6 | |
20 | Control/Ab4 | 41.4 | 48 | 52,500 | 2 | 31.32 | 7 | |
22 | Control/Ab4 | 41.2 | 36 | 28,000 | 2 | 32.89 | 8 |
NA, not applicable.
Body temperature >38.5°C considered a fever.
Virus isolation in nasal secretion (PFU/ml).
Detection by real-time PCR of EHV-1 gB in PBMC.
CT, cycle threshold.